Author details

Full Name

Sean M Grimmond

Affiliation

The University of Melbourne

ORCID

Career Start Year

1990

Papers

236

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
36179268	Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions.	Blood	2023
36179268	Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions.	Blood	2023
35738942	Primary pancreatic spindle cell sarcoma with a TMEM106B::BRAF gene fusion treated with MEK inhibition.	Pathology	2023
37686662	A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review.	Cancers (Basel)	2023
36828915	S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer.	Cell Death Differ	2023
37143137	Targeting homologous recombination deficiency in uterine leiomyosarcoma.	J Exp Clin Cancer Res	2023
36949280	Correction to: S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer.	Cell Death Differ	2023
36868206	Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.	Am J Hum Genet	2023
36624099	Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.	Nat Commun	2023
37686662	A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review.	Cancers (Basel)	2023
35738942	Primary pancreatic spindle cell sarcoma with a TMEM106B::BRAF gene fusion treated with MEK inhibition.	Pathology	2023
36949280	Correction to: S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer.	Cell Death Differ	2023
37143137	Targeting homologous recombination deficiency in uterine leiomyosarcoma.	J Exp Clin Cancer Res	2023
36624099	Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.	Nat Commun	2023
36868206	Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.	Am J Hum Genet	2023
36828915	S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer.	Cell Death Differ	2023
34256129	Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.	Semin Cancer Biol	2022
35381620	Methyl-CpG binding domain 4, DNA glycosylase (MBD4)-associated neoplasia syndrome associated with a homozygous missense variant in MBD4: Expansion of an emerging phenotype.	Br J Haematol	2022
35637530	Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.	Genome Med	2022
36271074	Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.	Nat Commun	2022
36699384	qmotif: determination of telomere content from whole-genome sequence data.	Bioinform Adv	2022
36480778	Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.	JCO Precis Oncol	2022
34175442	Clinical utility of whole-genome sequencing in precision oncology.	Semin Cancer Biol	2022
34119643	Analytical demands to use whole-genome sequencing in precision oncology.	Semin Cancer Biol	2022
34256129	Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.	Semin Cancer Biol	2022
35192684	Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.	Blood	2022
35381620	Methyl-CpG binding domain 4, DNA glycosylase (MBD4)-associated neoplasia syndrome associated with a homozygous missense variant in MBD4: Expansion of an emerging phenotype.	Br J Haematol	2022
35637530	Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.	Genome Med	2022
36480778	Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.	JCO Precis Oncol	2022
36699384	qmotif: determination of telomere content from whole-genome sequence data.	Bioinform Adv	2022
36271074	Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.	Nat Commun	2022
35192684	Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.	Blood	2022
34175442	Clinical utility of whole-genome sequencing in precision oncology.	Semin Cancer Biol	2022
34119643	Analytical demands to use whole-genome sequencing in precision oncology.	Semin Cancer Biol	2022
34680285	PRMT5: An Emerging Target for Pancreatic Adenocarcinoma.	Cancers (Basel)	2021
34680285	PRMT5: An Emerging Target for Pancreatic Adenocarcinoma.	Cancers (Basel)	2021
34638463	The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids.	Cancers (Basel)	2021
34586840	Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status.	Sci Adv	2021
34994633	Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma.	JCO Precis Oncol	2021
34994633	Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma.	JCO Precis Oncol	2021
34586840	Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status.	Sci Adv	2021
34638463	The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids.	Cancers (Basel)	2021
32402285	HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.	Cell Rep	2020
32358589	RAF1 rearrangements are common in pancreatic acinar cell carcinomas.	Mod Pathol	2020
32402285	HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.	Cell Rep	2020
32648276	Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia.	Br J Haematol	2020
32648276	Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia.	Br J Haematol	2020
32358589	RAF1 rearrangements are common in pancreatic acinar cell carcinomas.	Mod Pathol	2020
30417748	Platypus Induced Pluripotent Stem Cells: The Unique Pluripotency Signature of a Monotreme.	Stem Cells Dev	2019
30417748	Platypus Induced Pluripotent Stem Cells: The Unique Pluripotency Signature of a Monotreme.	Stem Cells Dev	2019

1 - 50 of 472

Hailiang Mei

Leiden University Medical Center

Career Start Year 2014

Number of shared co-authors 6

Tuo Zhang

Weill Cornell Medical College.

Career Start Year 2013

Number of shared co-authors 1

Matti Nykter

Prostate Cancer Research Center, Tampere University and Tays Cancer Center

Career Start Year 2006

Number of shared co-authors 8

Yue Lu

The University of Texas MD Anderson Cancer Center

Career Start Year 2006

Number of shared co-authors 0

Yongjun Zhao

Canada British Columbia Cancer Research Centre, University of British Columbia

Career Start Year 2005

Number of shared co-authors 30

Paul M Krzyzanowski

Ontario Institute for Cancer Research

Career Start Year 2005

Number of shared co-authors 22

Steffen Durinck

Genentech Inc.

Career Start Year 2004

Number of shared co-authors 8

Francesca Rizzo

University of Salerno and Genome Research Center for Health

Career Start Year 2004

Number of shared co-authors 7

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 1

Pedro A F Galante

Hospital Sirio Libanes

Career Start Year 2003

Number of shared co-authors 2

Peter White

The Ohio State University

Career Start Year 2000

Number of shared co-authors 5

Yan W Asmann

Mayo Clinic

Career Start Year 2000

Number of shared co-authors 4

Ru-Fang Yeh

Genentech Inc.

Career Start Year 1999

Number of shared co-authors 13

Jan Koster

Amsterdam University Medical Centers location AMC

Career Start Year 1999

Number of shared co-authors 28

Shawn Levy

HudsonAlpha Institute for Biotechnology

Career Start Year 1999

Number of shared co-authors 15

Braden Boone

HudsonAlpha Institute for Biotechnology

Career Start Year 1999

Number of shared co-authors 10

Celine Lefebvre

The Scripps Research Institute

Career Start Year 1999

Number of shared co-authors 0

Martin Hirst

University of British Columbia

Career Start Year 1998

Number of shared co-authors 36

Sarah J Wheelan

National Human Genome Research Institute, National Institutes of Health

Career Start Year 1998

Number of shared co-authors 11

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 22

Agnes Viale

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 15

Steven J M Jones

University of British Columbia

Career Start Year 1995

Number of shared co-authors 78

Anamaria A Camargo

Hospital Sirio-Libanes

Career Start Year 1994

Number of shared co-authors 5

Marco A Marra

University of British Columbia

Career Start Year 1993

Number of shared co-authors 80

Samuel Aparicio

University of British Columbia

Career Start Year 1993

Number of shared co-authors 28

Marie-Laure Yaspo

Max Planck Institute for Molecular Genetics

Career Start Year 1992

Number of shared co-authors 37

Abdel G Elkahloun

National Human Genome Research Institute

Career Start Year 1990

Number of shared co-authors 6

Shrikant Mane

Yale School of Medicine

Career Start Year 1989

Number of shared co-authors 7

Jiannis Ragoussis

McGill University

Career Start Year 1986

Number of shared co-authors 9

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 51

row(s) 1 - 30 of 30